Park Medi World IPO
IPO Listing Details
- Listing Date
17 Dec 2025
- Listing Price
₹155.60
- Listing Change
-3.95%
- Last Traded Price
₹145.50
Park Medi World IPO Details
-
Open Date
10 Dec 2025
-
Close Date
12 Dec 2025
-
Listing Date
17 Dec 2025
- IPO Price Range
₹ 154 to ₹162
- IPO Size
₹ 920 Cr
- Listing Exchange
BSE NSE
Park Medi World IPO Timeline
Park Medi World IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 10-Dec-2025 | 0.28 | 0.70 | 0.65 | 0.56 |
| 11-Dec-2025 | 0.34 | 1.46 | 1.26 | 1.04 |
| 12-Dec-2025 | 12.07 | 15.93 | 3.32 | 8.52 |
Last Updated: 15 December 2025 5:51 PM by 5paisa
Park Medi World Ltd is a private hospital chain in North India that operates under the "Park" brand. Founded in 2011, the company runs about 14 NABH-accredited multi-specialty hospitals. They offer more than 30 specialties, including cardiology, neurology, orthopaedics, oncology, and general surgery. By 2025, the bed capacity will be around 3,000 to 3,250 beds across Haryana, Delhi, Punjab, and Rajasthan. Park Medi World’s upcoming IPO targets around ₹920 crore, via a mix of fresh issue and offer-for-sale, to fund debt repayment, hospital expansion, equipment purchase and further growth.
Established in: 2011
Managing Director: Dr. Ankit Gupta
Peers:
| Name of Company | Park Medi World Limited | Apollo Hospitals Limited | Fortis Healthcare Limited | Global Health Limited | Jupiter Lifeline Hospitals Limited |
Max Healthcare Institute Limited |
|
Revenue From Operations (₹ Cr) |
1393.6 | 21816.5 | 7,73,9.96 | 3692.32 | 1257.86 | 8667.0 |
| PAT (₹ Cr) | 213.2 | 1505.1 | 809.38 | 481.32 | 193.5 | 1336.0 |
| PAT Margin (%) | 15.30 | 6.86 | 10.33 | 12.76 | 15.02 | 15.40 |
| ROE (%) | 20.68 | 22.32 | 18.96 | - | 15.23 | 35.93 |
Park Medi World Objectives
1. Repayment/ prepayment, in full or in part, of outstanding borrowings availed by the company and subsidiaries (₹380.0 Cr)
2. Funding capital expenditure for development of new hospital by our Subsidiary Park Medicity (NCR) (₹60.5 Cr)
3. Funding capital expenditure for purchase of medical equipment by the Company and subsidiaries, Blue Heavens and Ratangiri (₹27.5 Cr)
4. Unidentified inorganic acquisitions and general corporate purpose
Park Medi World Ltd IPO Size
| Types | Size |
|---|---|
| Total IPO Size | ₹920 Cr |
| Offer For Sale | ₹150 Cr |
| Fresh Issue | ₹770 Cr |
Park Medi World Ltd IPO Lot Size
| Application | Lots | Shares | Amount (₹) |
| Retail (Min) | 1 | 92 | 14,168 |
| Retail (Max) | 13 | 1,196 | 1,93,752 |
| S - HNI (Min) | 14 | 1,288 | 1,98,352 |
| S - HNI (Max) | 67 | 6,164 | 9,98,568 |
| B - HNI (Max) | 68 | 6,256 | 10,13,472 |
Park Medi World Ltd IPO Reservation
| Investors Category | Subscription (times) | Shares Offered* | Shares bid for | Total Amount (Cr.)* |
|---|---|---|---|---|
| QIB (Ex Anchor) | 12.07 | 1,13,58,026 | 13,71,09,808 | 2,221.179 |
| Non-Institutional Buyers | 15.93 | 85,18,519 | 13,57,18,492 | 2,198.640 |
| bNII (bids above ₹10L) | 18.34 | 56,79,012 | 10,41,55,592 | 1,687.321 |
| sNII (bids below ₹10L) | 11.12 | 28,39,507 | 3,15,62,900 | 511.319 |
| Individual Investors (IND category bidding for 2 Lots) | 3.32 | 1,98,76,543 | 6,60,01,168 | 1,069.219 |
| Total** | 8.52 | 3,97,53,088 | 33,88,29,468 | 5,489.037 |
*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.
| Particulars (In ₹ Crores) | FY23 | FY24 | FY25 |
| Revenue | 1393.6 | 1231.1 | 1254.6 |
| EBITDA | 390.3 | 310.3 | 372.2 |
| Profit After Tax (PAT) | 228.2 | 152.0 | 213.2 |
| Particulars (In ₹ Crores) | FY23 | FY24 | FY25 |
| Total Assets | 1592.8 | 1912.1 | 2133.7 |
| Share Capital | 76.9 | 76.9 | 76.9 |
| Total Liabilities | 1592.8 | 1912.1 | 2133.7 |
| Particulars (In ₹ Crores) | FY23 | FY24 | FY25 |
| Net Cash Generated From / (used in) Operating Activities | 195.0 | 361.4 | 191.2 |
| Net Cash Generated From / (used in) Investing Activities | -179.6 | -254.5 | -91.2 |
| Net Cash Generated From / (used in) Financing Activities | 1.5 | -130.3 | -73.6 |
| Net Increase / (Decrease) In Cash And Cash Equivalents | 16.9 | -23.4 | 26.4 |
Strengths
1. Large North India hospital network with strong bed capacity.
2. Multiple NABH/NABL-accredited multi-specialty centres.
3. Proven acquisition and integration record.
4. Healthy margins and experienced management.
Weaknesses
1. High revenue dependence on Haryana region.
2. Reliance on specialist doctors and medical staff.
3. High operating costs across multi-specialty hospitals.
4. Integration risk from acquired facilities.
Opportunities
1. Rising demand for quality care in tier-2/3 cities.
2. Strong expansion pipeline across new regions.
3. IPO funds to cut debt and support growth capex.
4. Growing need for tertiary care services.
Threats
1. Strong competition from private and government hospitals.
2. Regulatory changes may impact operations.
3. Seasonal and economic swings affect patient volumes.
4. Execution risks in expansion and acquisitions.
1. Strong regional presence as North India’s second-largest private hospital chain with sizable bed capacity.
2. Consistent revenue and profit growth, reflecting stable operations.
3. IPO funds aimed at debt reduction, expansion, and equipment upgrades to drive future growth.
4. Favourable industry tailwinds with rising demand for private healthcare in tier-2/3 markets.
Park Medi World Ltd is entering the public markets at a time when India’s private-hospital sector is growing rapidly. The overall domestic healthcare delivery industry rose from ₹3.9 lakh crore in FY 2019 to ₹6.3 lakh crore in FY 2024.
With a strong regional foothold, a network of NABH-accredited multi-specialty hospitals, and plans to use IPO proceeds for debt reduction, expansion and equipment upgrades, Park Medi World is positioned to capitalise on rising demand for quality private healthcare. If India’s private hospital market reaches the expected target of $202 billion by 2030, the company could leverage its growth plan to capture a meaningful share.
Open Free Demat Account
Be a part of 5paisa community - The first listed discount broker of India.
By proceeding, you agree to all T&C*
FAQs
Park Medi World Ltd IPO opens from December 10, 2025 to December 12, 2025.
The size of Park Medi World Ltd IPO is ₹920 Cr.
The price band of Park Medi World Ltd IPO is fixed at ₹154 to ₹162 per share.
To apply for Park Medi World Ltd IPO, follow the steps given below:
● Login to your 5paisa demat account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the PARK MEDI WORLD Ltd IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
You will receive a mandate notification to block funds in your UPI app.
The minimum lot size of Park Medi World Ltd IPO is of 92 shares and the investment required is ₹14,904.
The share allotment date of Park Medi World Ltd IPO is December 15, 2025
The Park Medi World Ltd IPO will likely be listed on 17 December 2025.
The book running lead managers for Park Medi World Ltd IPO are:
1. Nuvama Wealth Management Limited
2. CLSA India Private Limited
3. DAM Capital Advisors Limited
4. Intensive Fiscal Services Private Limited
Park Medi World Ltd IPO plans to utilise the raised capital from the IPO for:
1. Repayment/ prepayment, in full or in part, of outstanding borrowings availed by the company and subsidiaries (₹380.0 Cr)
2. Funding capital expenditure for development of new hospital by our Subsidiary Park Medicity (NCR) (₹60.5 Cr)
3. Funding capital expenditure for purchase of medical equipment by the Company and subsidiaries, Blue Heavens and Ratangiri (₹27.5 Cr)
4. Unidentified inorganic acquisitions and general corporate purpose
